Apollo Commercial Real Estate Finance (ARI) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
11 Feb, 2026Executive summary
Announced and entered a definitive agreement to sell the entire loan portfolio to Athene at 99.7% of total loan commitments, with focus shifting to managing and maximizing value from four retained REO assets.
Net income available to common stockholders was $114 million ($0.81 per diluted share) for 2025 and $26 million ($0.18 per diluted share) for Q4 2025.
Distributable earnings were $139 million ($0.98 per diluted share) for 2025 and $37 million ($0.26 per diluted share) for Q4.
Declared $1.00 per share in dividends for 2025, implying a 9.4% yield and 0.98x annual dividend coverage.
Ended 2025 with $151 million in liquidity and no corporate debt maturities until June 2029.
Financial highlights
Total loan portfolio stood at $8.8 billion, with a weighted-average unlevered all-in yield of 7.3%.
99% of loans are first mortgages and 96% are floating rate.
Book value per share at year-end was $12.14.
Q4 distributable earnings per share ($0.26) covered the $0.25 per share dividend.
Net interest income for 2025 was $166.7 million, with total net revenue of $271.6 million.
Outlook and guidance
Focus on completing lease-up and stabilization of The Brook, with exit timing dependent on market conditions.
The sale of the entire loan portfolio to Athene is expected to close, with two loans ($146 million) anticipated to be repaid prior to closing.
No corporate debt maturities until June 2029, supporting stable capital structure.
Dividend for Q1 2025 expected at $0.25 per share, subject to board approval; future dividends under review.
Mayflower hotel expected to see improved net cash flow after cost savings initiatives.
Latest events from Apollo Commercial Real Estate Finance
- $8.8B loan portfolio, 9.4% yield, and robust Apollo backing drive strong performance.ARI
Investor presentation9 Mar 2026 - Shareholders to vote on $9B asset sale to Athene, revised management fees, and future strategy.ARI
Proxy Filing9 Mar 2026 - Shareholders are asked to approve a $9B commercial loan sale to Athene, offering higher yields.ARI
Proxy Filing20 Feb 2026 - Portfolio sale prompts asset value maximization and strategic review, with shareholder vote pending.ARI
Proxy Filing12 Feb 2026 - Stockholders to vote on $9B asset transfer to Athene, aiming to enhance value and efficiency.ARI
Proxy Filing10 Feb 2026 - Proposed $9B real estate loan portfolio acquisition highlights disciplined, long-term strategy.ARI
Proxy Filing6 Feb 2026 - $9B real estate loan portfolio acquired with robust oversight and long-term investment focus.ARI
Proxy Filing6 Feb 2026 - $9B loan portfolio sale at 99.7% unlocks $1.4B cash, validates book, and enables strategic review.ARI
Status update3 Feb 2026 - Q2 distributable earnings $0.35/share; $90M CECL reserve expected for healthcare loan.ARI
Q2 20242 Feb 2026